New Edge Advisors, LLC Global X Fds Genomics & Biotec Transaction History

New Edge Advisors, LLC

$15 Billion
Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, New Edge Advisors, LLC holds 300 shares of GNOM stock, worth $2,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Holding current value

$2,991

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$10.32 - $11.8 $3,096 - $3,540	300 New	300 $3,000
Q4 2022 Feb 14, 2023	BUY	$12.08 - $13.81 $1,304 - $1,491	108 New	108 $1,000

Others Institutions Holding GNOM

# of Institutions

Shares Held

3.13M

Call Options Held

Put Options Held

200

One Capital Management, LLC Westlake Village, CA

730K
Shares

$7.28 Million
0.28% of portfolio
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL

337K
Shares

$3.36 Million
0.01% of portfolio
Portland Global Advisors LLC

260K
Shares

$2.59 Million
0.37% of portfolio
Mirae Asset Global Etfs Holdings Ltd. Central, K3

148K
Shares

$1.47 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

147K
Shares

$1.47 Million
0.0% of portfolio

View Full List

About GLOBAL X FDS GENOMICS & BIOTEC

Ticker GNOM
Sector ETFs
Industry ETFs

More about GNOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Global X Fds Genomics & Biotec Transaction History